Travere Therapeutics, Inc. (TVTX)

40.77 +1.23 (+3.11%) USD  |  NASDAQ  |  Apr 17, 16:00
40.80 +0.03 (+0.07%) Pre-Market: 20:00
More

Travere Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for TVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Revolution Medicines, Inc. --
ICU Medical, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
iRhythm Holdings, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade